AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 74 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -62.5% | 25,737 | -23.1% | 0.00% | – |
| Q1 2022 | $24,000 | -67.1% | 33,452 | +3.6% | 0.00% | – |
| Q4 2021 | $73,000 | +7.4% | 32,286 | +37.2% | 0.00% | – |
| Q3 2021 | $68,000 | +6.2% | 23,527 | +38.7% | 0.00% | – |
| Q2 2021 | $64,000 | +33.3% | 16,962 | +18.8% | 0.00% | – |
| Q1 2021 | $48,000 | +50.0% | 14,273 | +24.7% | 0.00% | – |
| Q4 2020 | $32,000 | -83.0% | 11,449 | -9.4% | 0.00% | -100.0% |
| Q4 2017 | $188,000 | +6166.7% | 12,641 | +4463.5% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 277 | +0.4% | 0.00% | – |
| Q4 2014 | $3,000 | – | 276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
| Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
| Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
| Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
| Ergoteles LLC | 849,000 | $300,000 | 0.01% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |